We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of JAMA Dermatology |

In This Issue of JAMA Dermatology FREE

JAMA Dermatol. 2013;149(2):135. doi:10.1001/jamadermatol.2013.2201.
Text Size: A A A
Published online

Psoriasis begins during childhood in 22% to 33% of cases, and recent studies have suggested an association of psoriasis with obesity in children. In this multicenter, cross-sectional study of 409 children with psoriasis, Paller et al demonstrate that globally, children with psoriasis have excess adiposity and increased central adiposity regardless of psoriasis severity. The underlying basis for the relationship between excess adiposity and psoriasis is not well understood, but the associated risks warrant early monitoring and lifestyle modification.

See Article

The Vitamin A derivative isotretinoin is approved for the treatment of severe recalcitrant nodulocystic acne. Recent reports of a possible link between isotretinoin and inflammatory bowel disease (IBD) have discouraged some dermatologists from prescribing this highly effective medication. In this nested case-control study and meta-analysis, Etminan et al demonstrate a lack of association between isotretinoin use and IBD. These data are consistent with other published studies. Given the high burden of psychological stress associated with cystic acne in adolescents, clinicians should not be discouraged from prescribing isotretinoin because of an unproven association with IBD.

See Article

Hepatitis C virus (HCV) treatment with pegylated interferon and ribavirin has been associated with skin eruptions that seldom lead to discontinuation of treatment. Adding the HCV protease inhibitor telaprevir, which may significantly increase the rate of sustained viral response, results in far higher rates of skin eruptions. In this case series, Roujeau et al demonstrate that dermatitis occurs in a majority of telaprevir-treated patients. Lesions often appear within 4 days of treatment and are described as eczematous rather than a more classic “maculopapular” drug eruption. Treatments for contact dermatitis or atopic dermatitis may help control telaprevir-related dermatitis, but clinicians are also alerted to an increased risk of Stevens-Johnson syndrome and DRESS (drug reaction with eosinophilia and systemic symptoms).

See Article

Laser surgery for aesthetic and medical therapy of the skin has proliferated tremendously for the past 2 decades. Unsurprisingly, increased use of laser technology has been associated with a concomitant increase in lawsuits alleging malpractice. In this search of online public documents using a national database, Jalian et al demonstrate that claims related to cutaneous laser surgery are increasing. Specific allegations provide insight into how physicians could minimize their risk of litigation. Nonphysicians performing laser procedures are held to a standard of care corresponding to an individual with appropriate training; thus, physicians are ultimately responsible for the actions of their nonphysician agents.

See Article

Scalp dysesthesia is described as a cutaneous syndrome characterized by pruritus, burning, stinging, or pain of the scalp in the absence of physical examination findings. Symptoms worsen with stress and are improved with low-dose antidepressant treatment. Other localized pruritic syndromes have been associated with pathologic conditions of the spine confirmed by cervical and thoracic spine imaging studies. In this case series, Thornsberry and English demonstrate that patients with scalp dysesthesia also had abnormal cervical spine images, suggesting that chronic muscle tension placed on the pericranial muscles and scalp aponeurosis may lead to the associated symptoms.

See Article

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.